At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled / 37 target
Drug / intervention
cochlear implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of the Safety and Performance of HiResTM Ultra Cl HiFocusTM SlimJ Electrode (Cl-1600-05) and HiResTM Ultra 3D Cl HiFocusTM SlimJ Electrode (Cl-1601-05) (Ultra X) in Adults With Severe-to-profound Hearing Loss
In Brief
An observational study evaluating cochlear implantation for Cochlear Hearing Loss. Completed, enrolled 37 participants across 3 sites.
Signals
Enrolling slower than its timeline implies
Detailed Summary
This is a prospective study designed to evaluate the safety and performance of the HiResTM Ultra Cl HiFocusTM SlimJ Electrode and HiResTM Ultra 3D Cl HiFocusTM SlimJ Electrode (Ultra X) under normal conditions of use as it is approved for this device. Participants receive interventions as part of routine medical care.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCochlear Hearing Loss
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJun 2021
Enrollment StartJul 2021
Primary CompletionFeb 2026
TodayJul 2026
First PostedJun 18, 2021
Enrollment StartJul 6, 2021
Primary CompletionFeb 5, 2026
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 5.0 years ago
Interventions
cochlear implantationdevice
patients receive a cochlear implantation within clinical routine